Home
Øystein Fluge's picture

Øystein Fluge

Professor
  • E-mailOystein.Fluge@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Pettersen, Ina Katrine Nitschke; Tusubira, Deusdedit; Ashrafi, Hanan; Dyrstad, Sissel Elisabeth; Hansen, Lena; Liu, Xiaozheng; Hodneland, Linn I.; Løvsletten, Nils Gunnar; Berge, Kjetil; Wergedahl, Hege; Bjørndal, Bodil; Fluge, Øystein; Bruland, Ove; Rustan, Arild; Halberg, Nils; Røsland, Gro Vatne; Berge, Rolf Kristian; Tronstad, Karl Johan. 2019. Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation. Mitochondrion (Amsterdam. Print). 97-110.
  • Simensen, Victoria C; Smeland, Knut Bjøro; Kiserud, Cecilie E.; Dahl, Alv A; Bersvendsen, Hanne Skjerven; Fluge, Øystein; Fagerli, Unn-Merete; Fosså, Alexander. 2019. Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma. Acta Oncologica. 1315-1322.
  • Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Seland, Mette; Wilsgaard, Tom; Smeland, Knut Bjøro; Kiserud, Cecilie E. 2019. Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation. Bone Marrow Transplantation. 1-15.
  • Giannoccaro, Maria Pia; Cossins, Judith; Sørland, Kari; Fluge, Øystein; Vincent, Angela. 2019. Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome. Clinical Therapeutics. 836-847.
  • Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid; Björkholm, Magnus; Enblad, Gunilla; Erlanson, Martin; Fluge, Øystein; Fohlin, Helena; Fosså, Alexander; Goldkuhl, Christina; Gustavsson, Anita; Johansson, Ann-Sofie; Linderoth, Johan; Nome, Ole; Palma, Marzia; Åkesson, Lisa; Østenstad, Bjørn; Raud, Cecilia; Glimelius, Bengt; Molin, Daniel. 2019. No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. British Journal of Haematology. 1-7.
  • Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Smeland, Knut Bjøro; Wilsgaard, Tom; Kiserud, Cecilie E. 2019. Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes. Acta Oncologica. 690-699.
  • Fluge, Øystein; Rekeland, Ingrid Gurvin; Lien, Katarina; Thurmer, Hanne; Borchgrevink, Petter Chr.; Schäfer, Christoph; Sørland, Kari; Assmus, Jörg; Ktoridou-Valen, Irini; Herder, Ingrid; Gotaas, Merethe Otelie Eide; Kvammen, Øivind; Baranowska, Katarzyna Anna; Bohnen, Louis Marie Leonardus Joseph; Martinsen, Sissel; Lonar, Ann Elin; Solvang, Ann-Elise Havnen; Gya, Arne Edvard Sørli; Bruland, Ove; Risa, Kristin; Alme, Kine; Dahl, Olav; Mella, Olav. 2019. B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine. 585-593.
  • Rekeland, Ingrid Gurvin; Fluge, Øystein; Alme, Kine; Risa, Kristin; Sørland, Kari; Mella, Olav; de Vries, Annick; Schjøtt, Jan. 2018. Rituximab serum concentrations and anti-rituximab antibodies during B-cell depletion therapy for myalgic encephalopathy/chronic fatigue syndrome. Clinical Therapeutics. 9.
  • Gunther, Oliver P; Gardy, Jennifer L; Stafford, Phillip; Fluge, Øystein; Mella, Olav; Tang, Patrick; Miller, Ruth R; Parker, Shoshana M; Johnston, Stephen A; Patrick, David M. 2018. Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Molecular Neurobiology. 1-9.
  • Smeland, Knut Bjøro; Loge, Jon Håvard; Aass, Hans Christian Dalsbotten; Aspelin, Trude; Bersvendsen, Hanne Skjerven; Bolstad, Nils; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Holte, Harald; Lund, May-Brith; Murbræch, Klaus; Reinertsen, Kristin Valborg; Stenehjem, Jo Steinson; Kiserud, Cecilie E. 2018. Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity. Bone Marrow Transplantation. 1-4.
  • Stensland, Marius; Klos, Jan; Fluge, Øystein; Helgeland, Lars; Meyer, Peter Albert. 2017. Extranodal NK/T-cell lymphoma, nasal type, primarily involving ovary. Human Pathology: Case Reports. 58-60.
  • Fluge, Øystein; Mannsåker, Bård; Torp, Anders; Mjaaland, Ingvil; Helgeland, Lars; Klos, Jan; Mella, Olav; Berentsen, Sigbjørn; Meyer, Peter Albert. 2017. Consolidative radiotherapy to residual masses after chemotherapy is associated with improved outcome in diffuse large B-cell lymphoma. A retrospective, population-based study. Clinical Lymphoma, Myeloma & Leukemia. 125-135.
  • Lunde, Sigrid; Kristoffersen, Einar Klæboe; Sapkota, Dipak; Risa, Kristin; Dahl, Olav; Bruland, Ove; Mella, Olav; Fluge, Øystein. 2016. Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. PLOS ONE.
  • Kiserud, Cecilie E.; Fagerli, Unn-Merete; Smeland, Knut Bjøro; Fluge, Øystein; Bersvendsen, Hanne; Kvaløy, Stein Olav; Holte, Harald; Dahl, Alv A. 2016. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncologica. 547-553.
  • Dale, Jon Espen; Sebjørnsen, Sigrunn; Leh, Sabine Maria; Røsler, Cornelia; Aaserud, Stein; Møller, Bjørn; Fluge, Øystein; Erichsen, Christian; Nadirpour, Saied; Kørner, Hartwig; Pfeffer, Frank; Dahl, Olav. 2016. Multimodal therapy is feasible in elderly anal cancer patients. Acta Oncologica. 81-87.
  • Fluge, Øystein; Mella, Olav; Bruland, Ove; Risa, Kristin; Dyrstad, Sissel Elisabeth; Alme, Kine; Rekeland, Ingrid Gurvin; Sapkota, Dipak; Røsland, Gro Vatne; Fosså, Alexander; Ktoridou-Valen, Irini; Lunde, Sigrid; Sørland, Kari; Lien, Katarina; Herder, Ingrid; Thurmer, Hanne; Gotaas, Merete E; Baranowska, Katarzyna Anna; Bohnen, Louis M.L.J.; Schäfer, Christoph; Mccann, Adrian; Sommerfelt, Kristian; Helgeland, Lars; Ueland, Per Magne; Dahl, Olav; Tronstad, Karl Johan. 2016. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight.
  • Fluge, Øystein; Thurmer, Hanne. 2016. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight.
  • Loebel, Madlen; Grabowski, Patricia; Heidecke, Harald; Bauer, Sandra; Hanitsch, Leif G.; Wittke, Kirsten; Meisel, Christian; Reinke, Petra; Volk, Hans-Dieter; Fluge, Øystein; Mella, Olav; Scheibenbogen, Carmen. 2016. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain, behavior, and immunity. 32-39.
  • Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Østenstad, Bjørn; Kvaløy, Stein Olav; Holte, Harald. 2016. A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. British Journal of Haematology. 432-443.
  • Pulczynski, Elisa J.; Kuittinen, Outi; Erlanson, Martin; Hagberg, Hans; Fosså, Alexander; Eriksson, Mikael; Nordström, Marie; Østenstad, Bjørn; Fluge, Øystein; Leppä, Sirpa; Fiirgaard, Bente; Bersvendsen, Hanne; Fagerli, Unn-Merete. 2015. Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group. Haematologica. 534-540.
  • Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Kvaløy, Stein Olav; Holte, Harald. 2015. Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. Haematologica. e240-e243.
  • Fluge, Øystein; Risa, Kristin; Lunde, Sigrid; Alme, Kine; Rekeland, Ingrid Gurvin; Sapkota, Dipak; Kristoffersen, Einar Klæboe; Sørland, Kari; Bruland, Ove; Dahl, Olav; Mella, Olav. 2015. B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. PLOS ONE.
  • Taskinen, Minna; Louhimo, Riku; Koivula, Satu; Chen, Ping; Rantanen, Ville; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Fjordén, Karin; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppä, Sirpa. 2014. Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma. PLOS ONE.
  • Knudsen-Baas, Kristin Marie; Moen, Gunnar; Fluge, Øystein; Storstein, Anette. 2013. Pseudoprogression in high-grade glioma. Acta Neurologica Scandinavica. 31-37.
  • Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Fluge, Øystein; Fosså, Alexander; Hammerstrøm, Jens; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Østenstad, Bjørn; Kvaløy, Stein Olav; Holte, Harald. 2013. High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008. Tidsskrift for Den norske legeforening. 1704-1709.
  • Holte, Harald; Leppä, Sirpa; Bjørkholm, Mikaela; Fluge, Øystein; Jyrkkio, S.; Delabie, Jan; Sundström, C.; Karjalainen-Lindsberg, Marja-Liisa; Erlanson, M.; Kolstad, Arne; Fosså, Alexander; Østenstad, Bjørn; Löfvenberg, E.; Nordstrøm, Marianne; Janes, R.; Pedersen, L.M.; Anderson, H.; Jerkeman, M.; Eriksson, M. 2013. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. Annals of Oncology. 1385-1392.
  • Riihijärvi, Sari; Nurmi, Heidi; Holte, Harald; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Rydström, Karin; Jerkeman, Mats; Eriksson, Mikael; Leppä, Sirpa. 2012. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy. European Journal of Haematology. 395-402.
  • Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H.; Rui, Hallgeir; Knudsen, Erik S.; Elsaleh, Hany; Fluge, Øystein; Vonen, Barthold; Myrvold, Helge Elliot; Leh, Sabine; Tveit, Magne Kjell; Pestell, Richard G.; Dahl, Olav. 2012. Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer. 1684-1691.
  • Myklebust, Mette Pernille; Fluge, Øystein; Immervoll, Heike ; Skarstein, Arne; Balteskard, Lise; Bruland, Ove; Dahl, Olav. 2012. Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. British Journal of Cancer. 756-762.
  • Myklebust, Mette Pernille; Bruland, Ove; Fluge, Øystein; Skarstein, Arne; Balteskard, Lise; Dahl, Olav. 2011. MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. British Journal of Cancer. 1719-1725.
  • Eide, Marianne Brodtkorb; Lauritzsen, Grete Fossum; Kvalheim, Gunnar; Kolstad, Arne; Fagerli, Unn-Merete; Maisenhölder, Martin; Østenstad, Bjørn; Fluge, Øystein; Delabie, Jan; Aarset, Harald; Liestøl, Knut; Holte, Harald. 2011. High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. British Journal of Haematology. 600-610.
  • Fluge, Øystein; Bruland, Ove; Risa, Kristin; Storstein, Anette; Kristoffersen, Einar Klæboe; Sapkota, Dipak; Næss, Halvor; Dahl, Olav; Nyland, Harald Inge; Mella, Olav. 2011. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLOS ONE. 13 pages.
  • Dresemann, Gregor; Weller, Michael; Rosenthal, Mark A.; Wedding, Ulrich; Wagner, Wolfgang; Engel, Erik; Heinrich, Bernhard; Mayer-Steinacker, Regine; Karup-Hansen, Anders; Fluge, Øystein; Nowak, Anna; Mehdorn, Maximillian; Schleyer, Eberhard; Krex, Dietmar; Olver, Ian N.; Steinbach, Joachim P.; Hosius, Christian; Sieder, Christian; Sorenson, Greg; Parker, Richard D.; Nikolova, Zariana. 2010. Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. Journal of Neuro-Oncology. 393-402.
  • Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove; Fluge, Øystein. 2009. Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. International Journal of Hyperthermia. 41-46.
  • Dahl, Olav; Fluge, Øystein; Carlsen, Erik; Wiig, Johan N; Myrvold, Helge E; Vonen, Barthold; Podhorny, Nina; Bjerkeset, Ottar; Eide, Tor Jacob; Halvorsen, T; Tveit, Kjell Magne. 2009. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncologica. 368-376.
  • Fluge, Øystein; Gravdal, K; Carlsen, Erik; Vonen, Barthold; Kjellevold, K; Refsum, S; Lilleng, R; Eide, Tor J.; Halvorsen, TB; Tveit, Kjell Magne; Otte, AP; Akslen, LA; Dahl, O. 2009. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer. 1282-1289.
  • Fluge, Øystein; Mella, Olav. 2009. Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. BMC Neurology. 7 pages.
  • Borkamo, Erling Dahl; Fluge, Øystein; Mella, Olav; Akslen, Lars A.; Bruland, Ove; Dahl, Olav. 2008. Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. Radiotherapy and Oncology. 435-442.
  • Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove; Fluge, Øystein. 2008. Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. International Journal of Hyperthermia. 425-441.
  • Bruland, Ove; Fluge, Øystein; Immervoll, Heike; Balteskard, Lise; Myklebust, Mette Pernille; Skarstein, Arne; Dahl, Olav. 2008. Gene expression reveals two distinct groups of anal carcinomas with clinical implications. British Journal of Cancer. 1264-1273.
  • Dahl, Olav; Borkamo, Erling Dahl; Fluge, Øystein. 2008. Current status of antivascular therapy and targeted treatment in the clinic. International Journal of Hyperthermia. 97-110.
  • Fluge, Øystein; Bruland, Ove; Akslen, Lars A.; Lillehaug, Johan; Varhaug, Jan Erik. 2006. Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid. 161-175.
  • Svanes, Cecilie; Omenaas, Ernst; Eide, Geir Egil; Fluge, Øystein; Gulsvik, Amund. 1998. Hospitalization for lung disease in early childhood and asthma symptoms in young adulthood. Respiratory Medicine. 1003-1009.
  • Fluge, Øystein; Omenaas, Ernst; Eide, Geir Egil; Gulsvik, Amund. 1998. Fish consumption and respiratory symptoms among young adults in a Norwegian community. European Respiratory Journal. 336-340.
Reader opinion piece
  • Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav. 2018. Kronisk utmattelsessyndrom og pyruvat dehydrogenasefunksjon . Tidsskrift for Den norske legeforening. 12-13.
  • Tronstad, Karl Johan; Fluge, Øystein; Lien, Katarina; Sommerfelt, Kristian; Mella, Olav. 2017. Mer om pyruvat dehydrogenase og kronisk utmattelsessyndrom. Tidsskrift for Den norske legeforening.
  • Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav. 2017. Chronic fatigue syndrome and pyruvate dehydrogenase function. Tidsskrift for Den norske legeforening.
Academic commentary
  • Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav. 2018. Kronisk utmattelsessyndrom og pyruvat dehydrogenasefunksjon.
Doctoral dissertation
  • Fluge, Øystein. 2004. Gene expression in papillary thyroid carcinomas, with special reference to tyrosine kinase receptors and growth factors.
Academic chapter/article/Conference paper
  • Christoffersen, Thoralf; Fluge, Øystein; Lehne, Gustav; Dahl, Olav. 2009. Kreftceller og kjemoterapi.
  • Lillehaug, Johan; Fluge, Øystein; Varhaug, Jan Erik. 2006. Thyroid Cancer: Molecular Biology and Clinical Aspects. 14 pages.
Abstract
  • Leppä, Sirpa; Taskinen, Minna; Koivula, Satu; Chen, Ping; Louhimo, Riku; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Moeller; Rydström, Karin; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Holte, Harald. 2012. Use of exon-based transcriptome profiling to identify novel signaling pathways and survival-associated genes in diffuse large B-cell lymphoma. Journal of Clinical Oncology. 1 pages.
  • Holte, Harald; Bogsrud, Trond; Leppa, S.; Laukka, M.; Bjørkholm, Mikaela; Jacobsson, H.; Jyrkkio, S.; Seppanen, M.; Jerkeman, Mats; Brun, E.; Fluge, Øystein; Pedersen, Lone Møller. 2011. (18)FDG PET/CT AFTER INTENSIFIED CHEMO-IMMUNOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), AGED 18-65 YEARS WITH AAIPI 2-3. POSITIVE OR INDETERMINATE LESIONS HAVE A LOW POSITIVE PREDICTIVE VALUE. A NORDIC PHASE II SUBSTUDY. Annals of Oncology. 159-159.
  • Holte, Harald; Leppä, Sirpa; Björkholm, Magnus; Fluge, Øystein; Jyrkkio, Sirkku; Delabie, Jan; Sundström, Christer; Karjalainen-Lindsberg, Marja-Liisa; Erlanson, Martin; Kolstad, Arne; Fosså, Alexander; Østenstad, Bjørn; Löfvenberg, Eva; Nordström, Marie; Pedersen, Lars Møller; Anderson, Harald; Jerkeman, Mats; Eriksson, Mikael. 2010. R-CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3: Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years. Blood. 1157-1157.
  • Riihijärvi, Sari; Nyman, Heidi; Holte, Harald; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Jerkeman, Mats; Eriksson, Mikael; Leppä, Sirpa. 2010. High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Dose-Dense Chemoimmunotherapy and Systemic CNS Prophylaxis. Results From a Nordic Phase II Study. Blood. 1686-1686.
  • Koivula, Satu; Taskinen, Minna; Chen, Ping; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppä, Sirpa. 2010. Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. Blood. 1281-1281.
  • Koivula, Satu; Taskinen, Minna; Chen, Ping; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppä, Sirpa. 2010. Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. Blood. 1281-1281.
Academic literature review
  • Dahl, Olav; Fluge, Øystein. 2008. Analkreft. 198-200.
Chapter
  • Christoffersen, Thoralf; Bruserud, Øystein; Fluge, Øystein; Lehne, Gustav; Dahl, Olav. 2016. Kreftbiologi og medikamentell terapi.

More information in national current research information system (CRIStin)